Elias Jabbour

Elias Jabbour

UNVERIFIED PROFILE

Are you Elias Jabbour?   Register this Author

Register author
Elias Jabbour

Elias Jabbour

Publications by authors named "Elias Jabbour"

Are you Elias Jabbour?   Register this Author

100Publications

2354Reads

48Profile Views

Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US.

J Med Econ 2019 Nov 31;22(11):1113-1118. Epub 2019 May 31.

Bristol-Myers Squibb , Princeton , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2019.1618316DOI Listing
November 2019

Recent advances in the treatment of acute lymphoblastic leukemia.

Leuk Lymphoma 2019 Nov 16;60(11):2606-2621. Epub 2019 May 16.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1605071DOI Listing
November 2019

Reply to Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Cancer 2019 Nov 10;125(21):3891-3892. Epub 2019 Jul 10.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32385DOI Listing
November 2019

Maintenance therapy in AML: The past, the present and the future.

Am J Hematol 2019 Nov 11;94(11):1254-1265. Epub 2019 Sep 11.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25620DOI Listing
November 2019

Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia.

Br J Haematol 2019 Nov 4;187(4):543-545. Epub 2019 Oct 4.

Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16245DOI Listing
November 2019

Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia.

Br J Haematol 2019 Sep 30. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16207DOI Listing
September 2019

SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia.

Clin Lymphoma Myeloma Leuk 2019 Aug 3;19(8):471-479. Epub 2019 Jul 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.06.011DOI Listing
August 2019

Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.

Biol Blood Marrow Transplant 2019 Jul 22;25(7):1271-1280. Epub 2019 Feb 22.

Department of Hematology and Cell Therapy, Acute Leukemia Working Party, European Society for Blood and Marrow Transplantation, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.02.018DOI Listing
July 2019

Therapy Options in Treating Acute Lymphoblastic Leukemia in Adults.

Authors:
Elias Jabbour

Oncology (Williston Park) 2019 Jul 16;33(7). Epub 2019 Jul 16.

View Article

Download full-text PDF

Source
July 2019

Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series.

Leuk Lymphoma 2019 Jun 27:1-4. Epub 2019 Jun 27.

b Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1633635DOI Listing
June 2019

Ibrutinib and Venetoclax for First-Line Treatment of CLL.

N Engl J Med 2019 05;380(22):2095-2103

From the Departments of Leukemia (N.J., M. Keating, P.T., A.F., J.B., G.B., K.T., Z.E., T.K., M. Konopleva, Y.A., M.Y., C.D., P.B., M.O., N.P., E.J., K. Sasaki, K. Sondermann, N.C., C.W., A.A., H.K., W.W.), Lymphoma and Myeloma (N.F.), Hematopathology (R.K.-S., K.P., J.J.), Diagnostic Radiology (N.G.), Biostatistics (X.W.), and Experimental Therapeutics (W.P., V.G.), University of Texas M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1900574DOI Listing
May 2019

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.

Ther Adv Hematol 2019 19;10:2040620719849496. Epub 2019 May 19.

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719849496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535741PMC
May 2019

Recent Advances in Adult Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2019 Apr;14(2):106-118

Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-019-00503-1DOI Listing
April 2019

Development of a symptom assessment in patients with myelofibrosis: qualitative study findings.

Health Qual Life Outcomes 2019 Apr 11;17(1):61. Epub 2019 Apr 11.

Guy's and St. Thomas' NHS Foundation Trust, St. Thomas Hospital, Westminster Bridge Rd. Lambeth, London, SE1 7EH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12955-019-1121-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460742PMC
April 2019

Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation.

J Clin Pathol 2019 Mar 22;72(3):251-257. Epub 2018 Nov 22.

Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2018-205399DOI Listing
March 2019

Treatment of relapsed/refractory acute lymphoblastic leukemia.

Clin Adv Hematol Oncol 2019 Mar;17(3):166-175

University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
March 2019

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.

Mod Pathol 2019 01 4;32(1):48-58. Epub 2018 Sep 4.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41379-018-0112-9
Publisher Site
http://dx.doi.org/10.1038/s41379-018-0112-9DOI Listing
January 2019

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Curr Treat Options Oncol 2019 01 24;20(1). Epub 2019 Jan 24.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 0428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-019-0603-z
Publisher Site
http://dx.doi.org/10.1007/s11864-019-0603-zDOI Listing
January 2019

Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia.

JAMA Oncol 2018 10;4(10):1413-1420

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.1915DOI Listing
October 2018

SOHO State of the Art Update and Next Questions: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Clin Lymphoma Myeloma Leuk 2018 07 22;18(7):439-446. Epub 2018 May 22.

Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.05.015DOI Listing
July 2018

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.

J Clin Oncol 2018 06 27;36(18):1788-1797. Epub 2018 Apr 27.

Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD Anderson Cancer Center, Houston, TX; Kiyomi Morita, The University of Tokyo, Tokyo; and Koichi Takahashi, Kyoto University, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.6757DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008108PMC
June 2018

Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia.

Cancer 2018 05 6;124(10):2151-2160. Epub 2018 Mar 6.

Adult Bone Marrow Transplant Unit, University Hospitals Bristol, National Health Service Foundation Trust, Bristol, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31317DOI Listing
May 2018

L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-induced Hyperbilirubinemia.

Clin Lymphoma Myeloma Leuk 2018 05 26;18(5):e191-e195. Epub 2018 Feb 26.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.02.014DOI Listing
May 2018

"Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL.

Clin Lymphoma Myeloma Leuk 2018 05 3;18(5):301-310. Epub 2018 Apr 3.

Onkologikum, Frankfurt am Museumsufer, Frankfurt, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.03.014DOI Listing
May 2018

Incorporating Immunotherapy Into the Treatment Strategies of B-Cell Adult Acute Lymphoblastic Leukemia: The Role of Blinatumomab and Inotuzumab Ozogamicin.

Am Soc Clin Oncol Educ Book 2018 May;38:574-578

From the Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/EDBK_199505
Publisher Site
http://dx.doi.org/10.1200/EDBK_199505DOI Listing
May 2018

Novel Therapies for Older Adults With Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2018 04;13(2):91-99

Department of Leukemia, Unit 428, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0440-3DOI Listing
April 2018

Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring.

Am J Hematol 2018 03;93(3):442-459

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25011DOI Listing
March 2018

Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives.

Clin Adv Hematol Oncol 2018 Mar;16(3):216-223

MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
March 2018